🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.

Several experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Service Response and Material Elimination

Based on TikTok, the service has removed problematic content and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive testimonials and detailed instructions for mixing or injecting at home.

Within moments of entering one community, a vendor posted contact information, where most transactions take place. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Product Information and Costs

Within these communities, messages show dark colored packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious health risks”.